These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8244180)

  • 1. Salvage therapy in ovarian cancer: is there a role for intraperitoneal drug delivery?
    Markman M
    Gynecol Oncol; 1993 Oct; 51(1):86-9. PubMed ID: 8244180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
    Markman M; Reichman B; Hakes T; Rubin S; Lewis JL; Jones W; Barakat R; Curtin J; Almadrones L; Hoskins W
    Gynecol Oncol; 1993 Jul; 50(1):100-4. PubMed ID: 8349150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of intraperitoneal therapy for ovarian cancer.
    Markman M
    Curr Opin Obstet Gynecol; 1993 Feb; 5(1):99-104. PubMed ID: 7678757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal Therapy of Ovarian Cancer.
    Markman M
    Oncologist; 1996; 1(1 & 2):18-21. PubMed ID: 10387964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intraperitoneal chemotherapy in the front-line setting.
    Markman M
    J Clin Oncol; 2003 May; 21(10 Suppl):145s-148s. PubMed ID: 12743130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal therapy of ovarian cancer.
    Markman M
    Semin Oncol; 1998 Jun; 25(3):356-60. PubMed ID: 9633848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study.
    Feun LG; Blessing JA; Major FJ; DiSaia PJ; Alvarez RD; Berek JS
    Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal chemotherapy in the management of malignant disease.
    Markman M
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide in the treatment of ovarian cancer.
    Markman M
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):47-9. PubMed ID: 8677449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer.
    Markman M
    Cancer J; 2009; 15(2):105-9. PubMed ID: 19390303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal cisplatin chemotherapy in the management of ovarian carcinoma.
    Markman M
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):79-82. PubMed ID: 2669140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.
    Rao G; Crispens M; Rothenberg ML
    J Clin Oncol; 2007 Jul; 25(20):2867-72. PubMed ID: 17617517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal cisplatin and carboplatin in the management of ovarian cancer.
    Markman M
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):17-9; quiz 20, 58. PubMed ID: 8202717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraperitoneal chemotherapy in ovarian carcinoma].
    Piura B
    Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal chemotherapy in ovarian cancer.
    Hofstra LS; de Vries EG; Mulder NH; Willemse PH
    Cancer Treat Rev; 2000 Apr; 26(2):133-43. PubMed ID: 10772970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal chemotherapy for ovarian cancer.
    Hamilton CA; Berek JS
    Curr Opin Oncol; 2006 Sep; 18(5):507-15. PubMed ID: 16894301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
    McCreath WA; Eisenhauer EL; Abu-Rustum NR; Venkatraman ES; Caceres A; Bier R; Huh J; Cho J; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Jul; 102(1):8-14. PubMed ID: 16427689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.